Novocure
NVCR
#4764
Rank
$1.29 B
Marketcap
Jersey
Country
$12.12
Share price
2.45%
Change (1 day)
-80.81%
Change (1 year)
Categories
P/S ratio for Novocure (NVCR)
P/S ratio as of April 2024 (TTM): 2.56
According to Novocure 's latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 2.55885. At the end of 2023 the company had a P/S ratio of 3.13.
P/S ratio history for Novocure from 2015 to 2023
PS ratio at the end of each year
| Year | P/S ratio | Change |
|---|---|---|
| 2023 | 3.13 | -78.12% |
| 2022 | 14.3 | -1.76% |
| 2021 | 14.6 | -59.11% |
| 2020 | 35.6 | 49.25% |
| 2019 | 23.9 | 89.69% |
| 2018 | 12.6 | 23.43% |
| 2017 | 10.2 | 24.07% |
| 2016 | 8.22 | -85.48% |
| 2015 | 56.6 |
P/S ratio for similar companies or competitors
| Company | P/S ratio | P/S ratio differencediff. | Country |
|---|---|---|---|
 Organovo ONVO | 42.9 | 1,574.62% | 🇺🇸 USA |
 Orchard Therapeutics
ORTX | 17.4 | 580.19% | 🇬🇧 UK |
 Novavax NVAX | 0.8739 | -65.85% | 🇺🇸 USA |
 Novocure
NVCR | 2.56 | 0.00% | Jersey |